Chronic Suppurative Otitis Media Clinical Presentation

  • Author: David Parry, MD; Chief Editor: Arlen D Meyers, MD, MBA   more...
 
Updated: Oct 13, 2011
 

History and Physical Examination

Patients with chronic suppurative otitis media (CSOM) present with a draining ear of some duration and a premorbid history of recurrent acute otitis media, traumatic perforation, or the placement of ventilation tubes. Typically, they deny pain or discomfort. A common presenting symptom is hearing loss in the affected ear. Reports of fever, vertigo, and pain should raise concern about intratemporal or intracranial complications. A history of persistent CSOM after appropriate medical treatment should alert the physician to consider cholesteatoma.

The external auditory canal may or may not be edematous and is not typically tender. The discharge varies from fetid, purulent, and cheeselike to clear and serous. Granulation tissue is often seen in the medial canal or middle ear space. The middle ear mucosa visualized through the perforation may be edematous or even polypoid, pale, or erythematous.

Next

Complications of Disease

In the present era of antibiotics, complications from CSOM are rarely seen because of early antibiotic intervention. However, surgery does play an important role in managing CSOM with or without cholesteatoma.

CSOM without prompt, proper treatment can progress to a variety of mild to life-threatening complications that can be separated into 2 subgroups: intratemporal and intracranial.[14] Intratemporal complications include petrositis, facial paralysis, and labyrinthitis. Intracranial complications include lateral sinus thrombophlebitis, meningitis, and intracranial abscess. Sequelae include hearing loss, acquired cholesteatoma, and tympanosclerosis.

Petrositis

Petrositis occurs when the infection extends beyond the confines of the middle ear and mastoid into the petrous apex. Patients may present with Gradenigo syndrome (ie, retro-orbital pain, aural discharge, and abducens palsy). A CT scan of the head and temporal bone helps define the extent of the disease, diagnose any intracranial spread, and plan a surgical approach. Treatment includes systemic antibiotics with petrosectomy.

Facial paralysis

Facial paralysis can be observed in CSOM with or without cholesteatoma. Surgical exploration with removal of diseased mucosa, granulation tissue, and inspissated pus (usually by mastoidectomy) should be undertaken promptly.

Labyrinthitis

Labyrinthitis occurs when the infection spreads to the inner ear. This may happen emergently or over an extended period. The infection gains access to the inner ear through the round and oval windows or through one of the semicircular canals exposed by bony erosion. The 4 categories of labyrinthitis have been recognized as acute serous, acute suppurative, chronic, and labyrinthine sclerosis.

The symptoms of acute serous labyrinthitis are acute onset of vertigo and hearing loss. Early surgical exploration to remove the infection mitigates damage to the labyrinth.

Patients with acute suppurative labyrinthitis present with profound hearing loss, tinnitus, and vertigo with associated nausea and vomiting. Patients initially demonstrate nystagmus with the rapid component directed toward the affected ear; they later demonstrate nystagmus away from the affected ear after destruction of the membranous labyrinth. Treatment includes aggressive surgical debridement (including labyrinthectomy) to prevent the possibly lethal intracranial complications of meningitis or encephalitis. Administration of broad-spectrum antibiotics with cerebrospinal fluid penetration is also necessary. Culture and sensitivities should direct any changes in the antibiotic regimen.

Chronic labyrinthitis is characterized by the gradual onset of vertigo, tinnitus, and hearing loss. Most commonly, the infection reaches the labyrinth through the lateral canal. Treatment involves mastoidectomy, culture, and appropriate medical therapy.

Labyrinthine sclerosis occurs as the inflammation in the labyrinth causes the body to replace it with fibrous tissue and new bone.

Lateral sinus thrombophlebitis

Lateral sinus thrombophlebitis occurs as the infection extends through the mastoid bone into the sigmoid or lateral sinus. The infected thrombus may release septic embolic causing distal infarcts. Patients present with altered mental status, possible seizures, and fever. Mastoidectomy with surgical excision of the thrombus and culture-directed antimicrobial treatment are the first steps in the management of sinus thrombophlebitis.

Meningitis

Meningitis develops as a consequence of direct or hematogenous spread of the infection. If meningitis is suspected, a lumbar puncture should be performed to recover the causative organism for culture and sensitivity prior to the initiation of empiric broad-spectrum antibiotic therapy. When stable, patients are taken to the operating room for surgical removal of the cholesteatoma or middle ear infection. Patients with CSOM may develop intracranial abscesses, but it is rare.

Intracranial abscesses

The various intracranial abscesses that may occur can be extradural, subdural, or parenchymal.

A patient with an extradural abscess may present with meningitic signs and symptoms or may be asymptomatic. Regardless of the presentation, imaging to define the abscess should be acquired, and the abscess should be drained with the assistance of neurosurgeons as needed.

Patients with subdural abscesses are very ill and exhibit meningeal signs, possible seizures, and hemiplegia. Prompt neurosurgical consultation, adequate imaging, drainage, and antibiotics are the appropriate treatment. Otologic surgery to remove the nidus of infection is necessary once the patient has stabilized.

Parenchymal abscesses occur as the infection spreads through the tegmen tympani or tegmen mastoideum to the temporal lobe or the cerebellum. Their presentation may be indolent, as this disease initially grows in "silent" areas of the brain. However, if the clinician suspects intracranial involvement, the previous plan of imaging, neurosurgical drainage, and antibiotic therapy is the standard of care.

Conductive hearing loss as a consequence of CSOM may result from the perforated tympanic membrane, a disruption in the ossicular chain, or both. Surgical removal of the infection and cholesteatoma with ossicular chain reconstruction mitigates morbidity associated with decreased hearing.

Previous
 
 
Contributor Information and Disclosures
Author

David Parry, MD  Staff Physician, Department of Otolaryngology-Head and Neck Surgery, ENT Associates of Children's Hospital, Boston

Disclosure: Nothing to disclose.

Coauthor(s)

Peter S Roland, MD  Professor, Department of Neurological Surgery, Professor and Chairman, Department of Otolaryngology-Head and Neck Surgery, Director of Clinical Center for Auditory, Vestibular and Facial Nerve Disorders, Chief of Pediatric Otology, University of Texas Southwestern Medical Center; Adjunct Professor of Communicative Disorders, University of Texas School of Human Development

Peter S Roland, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Otolaryngic Allergy, American Academy of Otolaryngology-Head and Neck Surgery, American Auditory Society, American Laryngological Rhinological and Otological Society, American Neurotology Society, American Otological Society, North American Skull Base Society, and Society of University Otolaryngologists-Head and Neck Surgeons

Disclosure: Alcon Labs Honoraria Speaking and teaching; GSK Honoraria Speaking and teaching; Advanced Bionics Honoraria Board membership; Cochlear Corp Honoraria Board membership; Med El Corp travel grants Consulting

Chief Editor

Arlen D Meyers, MD, MBA  Professor, Department of Otolaryngology-Head and Neck Surgery, University of Colorado School of Medicine

Arlen D Meyers, MD, MBA is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Head and Neck Society

Disclosure: Covidien Corp Consulting fee Consulting; US Tobacco Corporation Unrestricted gift Unknown; Axis Three Corporation Ownership interest Consulting; Omni Biosciences Ownership interest Consulting; Sentegra Ownership interest Board membership; Syndicom Ownership interest Consulting; Oxlo Consulting; Medvoy Ownership interest Management position; Cerescan Imaging Honoraria Consulting; GYRUS ACMI Honoraria Consulting

Additional Contributors

Anurag Jain, MBBS, FRCS(Ire), MS, FRCS(Oto), MS(Oto), DLO(RCSEngland) Specialist Registrar, Department of Otolaryngology, Pinderfields General Hospital, Wakefield, UK

Anurag Jain, MBBS, FRCS(Ire), MS, FRCS(Oto), MS(Oto), DLO(RCSEngland) is a member of the following medical societies: Association of Otolaryngologists of India, British Association of Otorhinolaryngologists, Head and Neck Surgeons, British Medical Association, Royal College of Surgeons in Ireland, and Royal College of Surgeons of England

Disclosure: Nothing to disclose.

Jeffrey Robert Knight, MBChB, FRCS Consulting Surgeon, Department of Otolaryngology, Mayday University Hospital, London

Disclosure: Nothing to disclose.

John C Li, MD Private Practice in Otology and Neurotology; Medical Director, Balance Center

John C Li, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, American Medical Association, American Neurotology Society, American Tinnitus Association, Florida Medical Association, and North American Skull Base Society

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Senior Pharmacy Editor, eMedicine

Disclosure: eMedicine Salary Employment

Peter A Weisskopf, MD Neurotologist, Arizona Otolaryngology Consultants; Head, Section of Neurotology, Barrow Neurological Institute

Peter A Weisskopf, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery and American College of Surgeons

Disclosure: Nothing to disclose.

References
  1. Matsuda Y, Kurita T, Ueda Y, Ito S, Nakashima T. Effect of tympanic membrane perforation on middle-ear sound transmission. J Laryngol Otol. May 2009;123 Suppl 31:81-9. [Medline].

  2. Wright D, Safranek S. Treatment of otitis media with perforated tympanic membrane. Am Fam Physician. Apr 15 2009;79(8):650, 654. [Medline].

  3. Vikram BK, Khaja N, Udayashankar SG, Venkatesha BK, Manjunath D. Clinico-epidemiological study of complicated and uncomplicated chronic suppurative otitis media. J Laryngol Otol. May 2008;122(5):442-6. [Medline].

  4. McKenzie W, Brothwell D. Disease in the Ear. Disease in Antiquity. 1967;464-73.

  5. Gregg JB, Steele JP, Holzhueter A. Roentgenographic evaluation of temporal bones from South Dakota Indian burials. American Journal of Physical Anthropology. 1965;23:51-62.

  6. Rathbun TA, Mallin R. Middle ear disease in a prehistoric Iranian population. Bull N Y Acad Med. Dec 1977;53(10):901-5. [Medline]. [Full Text].

  7. Meyerhoff WL, Kim CS, Paparella MM. Pathology of chronic otitis media. Ann Otol Rhinol Laryngol. Nov-Dec 1978;87(6 Pt 1):749-60. [Medline].

  8. Kenna MA. Microbiology of Chronic Suppurative Otitis Media. Ann Otol Rhinol Laryngol. 1988;97(suppl 131):9-10.

  9. Kenna MA. Etiology and Pathogenesis of Chronic Suppurative Otitis Media. Ann Otol Rhinol Laryngol. 1988;97(Suppl 131):16-17.

  10. Matsuda Y, Kurita T, Ueda Y, Ito S, Nakashima T. Effect of tympanic membrane perforation on middle-ear sound transmission. J Laryngol Otol. May 2009;123 Suppl 31:81-9. [Medline].

  11. Wright D, Safranek S. Treatment of otitis media with perforated tympanic membrane. Am Fam Physician. Apr 15 2009;79(8):650, 654. [Medline].

  12. van der Veen EL, Schilder AG, van Heerbeek N, et al. Predictors of chronic suppurative otitis media in children. Arch Otolaryngol Head Neck Surg. Oct 2006;132(10):1115-8. [Medline].

  13. Vikram BK, Khaja N, Udayashankar SG, Venkatesha BK, Manjunath D. Clinico-epidemiological study of complicated and uncomplicated chronic suppurative otitis media. J Laryngol Otol. May 2008;122(5):442-6. [Medline].

  14. Smith JA, Danner CJ. Complications of chronic otitis media and cholesteatoma. Otolaryngol Clin North Am. Dec 2006;39(6):1237-55. [Medline].

  15. Dohar JE. Old and New Ototopical Agents for the Acute and Chronic Draining Ear. Seminars in Otitis Media Management. 1. 1998;1-14.

  16. Dohar JE, Alper CM, Rose EA, Doyle WJ, Casselbrant ML, Kenna MA. Treatment of chronic suppurative otitis media with topical ciprofloxacin. Ann Otol Rhinol Laryngol. Oct 1998;107(10 Pt 1):865-71. [Medline].

  17. Dohar JE, Kenna MA, Wadowsky RM. Therapeutic implications in the treatment of aural Pseudomonas infections based on in vitro susceptibility patterns. Arch Otolaryngol Head Neck Surg. Sep 1995;121(9):1022-5. [Medline].

  18. Roland PS, Dohar JE, Lanier BJ, Hekkenburg R, Lane EM, Conroy PJ. Topical ciprofloxacin/dexamethasone otic suspension is superior to ofloxacin otic solution in the treatment of granulation tissue in children with acute otitis media with otorrhea through tympanostomy tubes. Otolaryngol Head Neck Surg. Jun 2004;130(6):736-41. [Medline].

  19. Consensus Panel, Hannley MT, Dennenny III JC. Use of Ototopical Antibiotics in Treating 3 Common Ear Diseases. Otol Head Neck Surg. 2000;934-40.

  20. Somekh E, Cordova Z. Ceftazidime versus aztreonam in the treatment of pseudomonal chronic suppurative otitis media in children. Scand J Infect Dis. 2000;32(2):197-9. [Medline].

  21. Bégué P, Garabédian EN, Bertrand C, Aubert B, Chiche D. Penetration of ceftazidime into middle ear fluid in children with otitis media with effusion. Laryngoscope. May 1998;108(5):662-4.

Previous
Next
 
Anatomy of the external and middle ear.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.